Skip to Main Navigation

KENYA COVID-19 HEALTH EMERGENCY RESPONSE PROJECT

Abstract*

The development objective of COVID-19 (Coronavirus) Emergency Response project for Kenya is to prevent, detect and respond to the threat posed by COVID-19 (Coronavirus) and strengthen national systems for public health preparedness. This project has seven components. 1) The first component, Medical Supplies and Equipment, aims to improve the availability of supplies and equipment needed to respond to COVD-19 (Coronavirus) and other public health emergencies...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness.

Key Details

Project Details

  • P173820

  • Active

  • Jane Chuma , Toni Kuguru

  • Republic of Kenya

  • Kenya

  • March 24, 2020

  • (as of board presentation)

    April 2, 2020

  • April 8, 2020

  • US$ 106.43 million

  • N/A

  • February 23, 2024

  • March 31, 2025

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
Freestanding Tfs - Health, Nutrition & Population GP 3.53
IDA Credit 100.00
Pandemic Emergency Financing Facility 2.90

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 100.00
IBRD + IDA Commitment 100.00
Lending Instrument
Grant Amount 6.43
Total Project Cost** 50.00

Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of February 28, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Oct 17, 2022 IDA-65980 Loan Disb 36,234.34
Jan 3, 2022 IDA-65980 Loan Disb 48,943.20
Dec 30, 2021 IDA-65980 Loan Disb 59,664.80
Sep 9, 2022 IDA-65980 Loan Disb 57,393.35
Sep 9, 2022 IDA-65980 Loan Disb 80,855.77
Feb 7, 2022 IDA-65980 Loan Disb 200,816.69
Oct 19, 2022 IDA-65980 Loan Disb 15,185.89
Jun 24, 2022 IDA-65980 Loan Disb 21,503.22
Jun 24, 2022 IDA-65980 Loan Disb 30,144.70
Jun 30, 2022 IDA-68230 Loan Disb 20,800,000.00
May 26, 2022 IDA-65980 Loan Disb 63,795.76
Apr 1, 2022 IDA-65980 Loan Disb 32,285.06
May 15, 2022 IDA-65980 Int Charges 4,297.95
May 15, 2022 IDA-65980 Int Charges 123,916.20
May 15, 2022 IDA-65980 Int Charges 123,916.20
May 15, 2022 IDA-65980 Int Charges 74,305.27
May 24, 2022 IDA-65980 Loan Disb 35,165.23
Jul 12, 2022 IDA-65980 Loan Disb 17,374.58
Jul 15, 2022 IDA-69600 Loan Disb 3,315,066.50
Mar 3, 2022 IDA-65980 Loan Disb 58,965.38
Oct 28, 2021 IDA-65980 Loan Disb 5,058,204.00
Nov 15, 2021 IDA-65980 Int Charges 1,017.55
Nov 15, 2021 IDA-65980 Int Charges 110,512.44
Nov 15, 2021 IDA-65980 Int Charges 110,512.44
Sep 23, 2021 IDA-65980 Loan Disb 512,344.03
Nov 15, 2021 IDA-65980 Int Charges 61,569.73
Jun 14, 2021 IDA-65980 Loan Disb 178,882.83
Jan 21, 2021 IDA-68230 Loan Commitment 50,000,000.00
Jun 28, 2021 IDA-69600 Loan Commitment 130,000,000.00
Apr 2, 2020 IDA-65980 Loan Commitment 50,000,000.00
Jun 7, 2024 IDA-65980 Loan Disb 56,452.35
May 15, 2024 IDA-65980 Int Charges 570.89
May 15, 2024 IDA-65980 Int Charges 134,346.86
May 15, 2024 IDA-65980 Int Charges 134,346.86
Jul 15, 2024 IDA-68230 Int Charges 81,825.00
Jul 15, 2024 IDA-68230 Int Charges 81,825.00
Apr 18, 2024 IDA-65980 Loan Disb 108,664.71
Apr 15, 2024 IDA-69600 Int Charges 7,839.18
Apr 5, 2024 IDA-65980 Loan Disb 63,321.91
Feb 23, 2024 IDA-65980 Loan Disb 71,039.65
Feb 22, 2022 IDA-69600 Loan Disb 7,388,787.50
Nov 2, 2021 IDA-65980 Loan Disb 938,199.10
Sep 14, 2021 IDA-65980 Loan Disb 27,922.82
Oct 26, 2021 IDA-65980 Loan Disb 944,107.10
Nov 5, 2021 IDA-65980 Loan Disb 156,065.20
Nov 17, 2020 IDA-65980 Int Charges 11,382.12
Nov 17, 2020 IDA-65980 Int Charges 11,382.12
Nov 17, 2020 IDA-65980 Int Charges 6,829.28
Nov 17, 2020 IDA-65980 Int Charges 94,121.04
Nov 17, 2020 IDA-65980 Int Charges 94,121.04
Nov 17, 2020 IDA-65980 Int Charges 56,472.62
May 15, 2021 IDA-65980 Int Charges 107,140.76
May 15, 2021 IDA-65980 Int Charges 107,140.76
May 15, 2021 IDA-65980 Int Charges 63,207.96
Apr 6, 2021 IDA-65980 Loan Disb 116,483.12
Apr 6, 2021 IDA-65980 Loan Disb 447,150.66
Apr 6, 2021 IDA-65980 Loan Disb 96,444.26
Apr 6, 2021 IDA-65980 Loan Disb 122,483.52
Apr 6, 2021 IDA-65980 Loan Disb 24,609.11
Apr 22, 2020 IDA-65980 Loan Disb 21,742,000.00
Jun 22, 2020 IDA-65980 Loan Disb 1,598,432.10
Jan 6, 2021 IDA-65980 Loan Disb 3,461,021.20
Oct 15, 2023 IDA-69600 Int Charges 7,736.94
Oct 15, 2023 IDA-69600 Int Charges 38,684.66
Oct 15, 2023 IDA-69600 Int Charges 38,684.66
Oct 15, 2022 IDA-69600 Int Charges 7,000.04
Nov 15, 2022 IDA-65980 Int Charges 44.55
Nov 15, 2022 IDA-65980 Int Charges 125,770.71
Nov 15, 2022 IDA-65980 Int Charges 125,770.71
Nov 15, 2022 IDA-65980 Int Charges 75,268.14
Nov 17, 2022 IDA-65980 Loan Disb 18,436.16
Nov 17, 2022 IDA-65980 Loan Disb 28,092.89
Oct 15, 2022 IDA-69600 Int Charges 7,000.04
Oct 15, 2022 IDA-69600 Int Charges 1,400.01
Oct 15, 2022 IDA-69600 Int Charges 29,789.29
Oct 15, 2022 IDA-69600 Int Charges 29,789.29
Sep 12, 2022 IDA-65980 Loan Disb 23,332.39
Sep 12, 2022 IDA-65980 Loan Disb 13,586.66
Oct 15, 2022 IDA-69600 Int Charges 5,957.87
Apr 15, 2023 IDA-69600 Int Charges 40,672.59
Apr 15, 2023 IDA-69600 Int Charges 40,672.59
Apr 15, 2023 IDA-69600 Int Charges 8,134.52
Jan 15, 2023 IDA-68230 Int Charges 1,982.20
Jan 15, 2023 IDA-68230 Int Charges 23,786.42
Mar 1, 2022 IDA-65980 Loan Disb 22,063.21
Mar 1, 2022 IDA-65980 Loan Disb 24,704.67
Dec 30, 2021 IDA-65980 Loan Disb -59,044.51
Oct 17, 2022 IDA-65980 Loan Disb 12,537.22
Oct 17, 2022 IDA-65980 Loan Disb 119,350.39
Oct 17, 2022 IDA-65980 Loan Disb 12,742.91
Jan 15, 2024 IDA-68230 Int Charges 82,091.25
Jan 15, 2024 IDA-68230 Int Charges 82,091.25
Jan 15, 2024 IDA-68230 Int Charges 24,080.12
May 15, 2024 IDA-65980 Int Charges 80,277.54
Apr 24, 2024 IDA-65980 Loan Disb 207,404.12
Jul 15, 2024 IDA-68230 Int Charges 24,002.02
Nov 15, 2023 IDA-65980 Int Charges 133,207.25
Dec 15, 2023 IDA-65980 Loan Disb 57,947.23
Nov 15, 2023 IDA-65980 Int Charges 133,207.25
Nov 15, 2023 IDA-65980 Int Charges 79,351.32
Jan 10, 2024 IDA-65980 Loan Disb 30,227.19
Apr 15, 2024 IDA-69600 Int Charges 39,195.89
Apr 15, 2024 IDA-69600 Int Charges 39,195.89
May 15, 2023 IDA-65980 Int Charges 203.01
May 15, 2023 IDA-65980 Int Charges 132,831.06
May 15, 2023 IDA-65980 Int Charges 132,831.06
May 15, 2023 IDA-65980 Int Charges 79,698.66
Aug 25, 2023 IDA-65980 Loan Disb 107,865.14
Sep 21, 2023 IDA-65980 Loan Disb 136,033.05
Sep 21, 2023 IDA-65980 Loan Disb 51,361.93
Sep 21, 2023 IDA-65980 Loan Disb 16,787.63
Sep 21, 2023 IDA-65980 Loan Disb 76,538.05
Sep 21, 2023 IDA-65980 Loan Disb 31,344.58
Jan 15, 2023 IDA-68230 Int Charges 6,757.50
Jan 15, 2023 IDA-68230 Int Charges 6,757.50
Jan 15, 2023 IDA-68230 Int Charges 81,090.00
Jan 15, 2023 IDA-68230 Int Charges 81,090.00
Jul 15, 2023 IDA-68230 Int Charges 84,150.00
Jul 15, 2023 IDA-68230 Int Charges 84,150.00
Jul 15, 2023 IDA-68230 Int Charges 24,684.02

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Project Management Moderately Satisfactory 2024-08-14
Monitoring and Evaluation Satisfactory 2024-08-14
Overall Implementation Progress (IP) Moderately Satisfactory 2024-08-14
Procurement Moderately Satisfactory 2024-08-14
Progress towards achievement of PDO Satisfactory 2024-08-14
Financial Management Moderately Satisfactory 2024-08-14

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of suspected cases of COVID-19 cases reported and investigated based on national guidelinesValue0.00100.0080.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagentsValue2.0031.0024.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Percentage of people who know at least 3 measures to prevent COVID-19Value0.0084.0080.00
    DateSeptember 25, 2020November 13, 2023March 31, 2025
    Comment
  • Percentage of safe blood available for transfusion in the countryValue22.0070.7080.00
    DateSeptember 18, 2020November 13, 2023March 31, 2025
    Comment
  • Percentage of population fully vaccinated as targeted in national plan (by gender)Value0.0038.8554.00
    DateJune 1, 2021November 13, 2023March 31, 2025
    Comment
  • NPHI operationalizedValueNoNoYes
    DateNovember 2, 2020November 13, 2023March 31, 2025
    Comment
  • Female population vaccinatedValue0.0053.4050.00
    DateJune 1, 2021November 13, 2023March 31, 2025
    Comment
  • Male population vaccinatedValue0.0046.6050.00
    DateJune 1, 2021November 13, 2023March 31, 2025
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of health workers trained in all capacity building modules for GBV health sector responseValue0.00325.00100.00
    DateSeptember 25, 2020November 13, 2023March 31, 2025
    Comment
  • Number of healthcare workers trained on IPCValue0.001707.00945.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Percentage of designated blood transfusion centers (regional and satellite centers) with TTI diagnostic equipment and reagentsValue0.00100.0080.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Number of designated referral facilities renovated/constructedValue0.001.002.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Number of covid-19 designated health facilities and labs with waste treatment equipment installed and functionalValue0.000.0012.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Percentage of designated facilities that have functional handheld infrared thermometers to screen COVID-19 as per MOH guidelinesValue0.00100.0080.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Number of Health Sector Action Plans for GBV developed as informed by results of quality assurance toolValue0.000.0010.00
    DateSeptember 25, 2020November 13, 2023March 31, 2025
    Comment
  • Number of lab staff trained on sample collection and packagingValue0.00552.00500.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Percentage of KNBTS satellite centers linked to and using blood service information systemValue0.0070.0080.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Number of incinerator operators trainedValue0.000.001778.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Number of testing equipment supplied to testing facilitiesValue0.0017.0017.00
    DateSeptember 25, 2020November 13, 2023March 31, 2025
    Comment
  • Assessment conducted to identify behavioral and socio-cultural risk factors for COVID-19ValueNoYesYes
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Number of county vaccine stores equipped with a cold roomValue0.000.0025.00
    DateJune 1, 2021November 13, 2023March 31, 2025
    Comment
  • Percentage of vulnerable and marginalized communities reached in their indigenous languageValue0.0079.0080.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Percentage of complaints to the GRM satisfactorily addressed within 4 weeks of initial complaint being recorded.Value0.00100.0080.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Number of surge capacity health workers contracted and deployed for case managementValue0.00477.00300.00
    DateApril 13, 2020November 13, 2023March 31, 2025
    Comment
  • Percentage of beneficiaries reporting community engagement and outreach meet their needsValue0.0087.0080.00
    DateSeptember 25, 2020November 13, 2023March 31, 2025
    Comment
  • NPHI strategic plan developedValueNoNoYes
    DateSeptember 25, 2020November 13, 2023March 31, 2025
    Comment